These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7849311)

  • 1. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
    Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
    Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
    Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
    Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
    Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
    Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
    Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
    Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 gene homozygous deletions in acute lymphoblastic leukemia.
    Quesnel B; Preudhomme C; Philippe N; Vanrumbeke M; Dervite I; Lai JL; Bauters F; Wattel E; Fenaux P
    Blood; 1995 Feb; 85(3):657-63. PubMed ID: 7833469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B- and T-cell origin but is frequent in acute lymphoblastic leukaemia.
    Schröder M; Mathieu U; Dreyling MH; Bohlander SK; Hagemeijer A; Beverloo BH; Olopade OI; Stilgenbauer S; Fischer K; Bentz M
    Br J Haematol; 1995 Dec; 91(4):865-70. PubMed ID: 8547131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
    Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
    Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
    Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
    Jagasia AA; Block JA; Qureshi A; Diaz MO; Nobori T; Gitelis S; Iyer AP
    Cancer Lett; 1996 Jul; 105(1):91-103. PubMed ID: 8689637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.
    Iolascon A; Faienza MF; Coppola B; della Ragione F; Schettini F; Biondi A
    Leukemia; 1996 Feb; 10(2):255-60. PubMed ID: 8637234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
    Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FISH analysis of translocations involving the short arm of chromosome 9 in lymphoid malignancies.
    Leblanc T; Derré J; Flexor M; Le Coniat M; Leroux D; Rimokh R; Larsen CJ; Berger R
    Genes Chromosomes Cancer; 1997 Aug; 19(4):273-7. PubMed ID: 9258663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
    Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
    Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
    Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
    Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas.
    Uchida T; Watanabe T; Kinoshita T; Murate T; Saito H; Hotta T
    Blood; 1995 Oct; 86(7):2724-31. PubMed ID: 7670111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia.
    Zhou M; Gu L; James CD; He J; Yeager AM; Smith SD; Findley HW
    Leukemia; 1995 Jul; 9(7):1159-61. PubMed ID: 7630190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
    Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
    Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.